Aave Warns $71m Exploit Recovery Seizure in Court Fight
Aave asks a New York court to lift a restraining order on ETH set aside for victims of a DeFi breach, arguing the ass...
Which Credit Cards Offer Cash Back No Fees
Explore the best credit cards that provide cash back without any fees. Start saving more on your purchases!
26,647 articles
Bitcoin Price: Can’t Close Above the 200‑Day MA Today
Bitcoin remains stuck below its long-running 200-day moving average, trading near $58,000 as of mid‑May 2026. A decis...
Zillow, MRED Face July Hearing Over Listing Feeds This Week
A Chicago federal judge has ordered MRED to restore certain listing feeds to Zillow while the zillow, mred face july ...
XRP Outlook From AI-Driven 10,000 Simulations Through 2027
A new Monte Carlo analysis maps XRP price paths through 2027 using 10,000 simulations, highlighting how regulatory ac...
AI Demand Sets Marvell and Micron on Diverging Paths
As the AI build-out accelerates, Marvell and Micron report results that highlight two distinct routes to profit: cust...
Prediction: This Stock Going to Plummet in H2 2026 Markets
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
Cerebras’ Mind-Boggling Speed Still Faces Nvidia Trap
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...
Traders Sue Polymarket Over Disputed Market Resolution
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
The Case for Holding DGRO in Your Roth IRA Today
As market conditions evolve in 2026, DGRO’s dividend growth and low costs make a compelling case for holding DGRO in ...
Musk, Altman, China Fight for Brain Implant Market
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
2026 Social Security COLA Fails Retirees, Shrinks Gains
The 2026 social security cola increased by 2.8%, yet rising Medicare premiums swallowed much of the bump, highlightin...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status